{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:02:00Z","timestamp":1794016920575,"version":"4.8.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BroadIgnite at the Broad Institute of MIT and Harvard"},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U24-CA271075"],"award-info":[{"award-number":["U24-CA271075"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA270823"],"award-info":[{"award-number":["U24CA270823"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA271402"],"award-info":[{"award-number":["U01CA271402"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA270823"],"award-info":[{"award-number":["U24CA270823"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA270823"],"award-info":[{"award-number":["U24CA270823"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA271402"],"award-info":[{"award-number":["U01CA271402"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Serial multi-omic analysis of proteome, phosphoproteome, and acetylome provides insights into changes in protein expression, cell signaling, cross-talk and epigenetic pathways involved in disease pathology and treatment. However, ubiquitylome and HLA peptidome data collection used to understand protein degradation and antigen presentation have not together been serialized, and instead require separate samples for parallel processing using distinct protocols. Here we present MONTE, a highly sensitive multi-omic native tissue enrichment workflow, that enables serial, deep-scale analysis of HLA-I and HLA-II immunopeptidome, ubiquitylome, proteome, phosphoproteome, and acetylome from the same tissue sample. We demonstrate that the depth of coverage and quantitative precision of each \u2018ome is not compromised by serialization, and the addition of HLA immunopeptidomics enables the identification of peptides derived from cancer\/testis antigens and patient specific neoantigens. We evaluate the technical feasibility of the MONTE workflow using a small cohort of patient lung adenocarcinoma tumors.<\/jats:p>","DOI":"10.1038\/s41467-023-37547-0","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:03:52Z","timestamp":1680519832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5262-7241","authenticated-orcid":false,"given":"Jennifer G.","family":"Abelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Bergstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-9576","authenticated-orcid":false,"given":"Keith D.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2146-8764","authenticated-orcid":false,"given":"Hannah B.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0074-5163","authenticated-orcid":false,"given":"Susan","family":"Klaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva K.","family":"Verzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jackson White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilina B.","family":"Woldemichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Virshup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8287-9474","authenticated-orcid":false,"given":"Meagan E.","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myranda","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Vartany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8951-0677","authenticated-orcid":false,"given":"Joseph D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshiti","family":"Phulphagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-824X","authenticated-orcid":false,"given":"M.","family":"Harry Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanna","family":"Rachimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-133X","authenticated-orcid":false,"given":"D. R.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-1448","authenticated-orcid":false,"given":"Michael A.","family":"Gillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6040-4854","authenticated-orcid":false,"given":"Shankha","family":"Satpathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl R.","family":"Clauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5312-1402","authenticated-orcid":false,"given":"Namrata D.","family":"Udeshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-4299","authenticated-orcid":false,"given":"Steven A.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"37547_CR1","doi-asserted-by":"publisher","first-page":"O111.011833","DOI":"10.1074\/mcp.O111.011833","volume":"10","author":"A Admon","year":"2011","unstructured":"Admon, A. & Bassani-Sternberg, M. The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing. Mol. Cell. Proteom. 10, O111.011833 (2011).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR2","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.1038\/ncomms13404","volume":"7","author":"M Bassani-Sternberg","year":"2016","unstructured":"Bassani-Sternberg, M. et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat. Commun. 7, 13404\u201313404 (2016).","journal-title":"Nat. Commun."},{"key":"37547_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14175-1","volume":"11","author":"ND Udeshi","year":"2020","unstructured":"Udeshi, N. D. et al. Rapid and deep-scale ubiquitylation profiling for biology and translational research. Nat. Commun. 11, 359 (2020).","journal-title":"Nat. Commun."},{"key":"37547_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nmeth.2518","volume":"10","author":"P Mertins","year":"2013","unstructured":"Mertins, P. et al. Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat. Methods 10, 634\u2013637 (2013).","journal-title":"Nat. Methods"},{"key":"37547_CR5","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1074\/mcp.O114.047555","volume":"14","author":"T Svinkina","year":"2015","unstructured":"Svinkina, T. et al. Deep, quantitative coverage of the lysine acetylome using novel anti-acetyl-lysine antibodies and an optimized proteomic workflow. Mol. Cell. Proteom. 14, 2429\u20132440 (2015).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR6","doi-asserted-by":"publisher","first-page":"e002071","DOI":"10.1136\/jitc-2020-002071","volume":"9","author":"A Marcu","year":"2021","unstructured":"Marcu, A. et al. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. J. Immunother. Cancer 9, e002071 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"37547_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","volume":"46","author":"JG Abelin","year":"2017","unstructured":"Abelin, J. G. et al. Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction. Immunity 46, 315\u2013326 (2017).","journal-title":"Immunity"},{"key":"37547_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","volume":"38","author":"S Sarkizova","year":"2020","unstructured":"Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199\u2013209 (2020).","journal-title":"Nat. Biotechnol."},{"key":"37547_CR9","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834\u2013840 (2009).","journal-title":"Science"},{"key":"37547_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","volume":"44","author":"W Kim","year":"2011","unstructured":"Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325\u2013340 (2011).","journal-title":"Mol. Cell"},{"key":"37547_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-022-00446-5","volume":"22","author":"DR Mani","year":"2022","unstructured":"Mani, D. R. et al. Cancer proteogenomics: current impact and future prospects. Nat. Rev. Cancer 22, 298\u2013313 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"37547_CR12","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2021.02.055","volume":"184","author":"H Rodriguez","year":"2021","unstructured":"Rodriguez, H., Zenklusen, J. C., Staudt, L. M., Doroshow, J. H. & Lowy, D. R. The next horizon in precision oncology: proteogenomics to inform cancer diagnosis and treatment. Cell 184, 1661\u20131670 (2021).","journal-title":"Cell"},{"key":"37547_CR13","doi-asserted-by":"publisher","unstructured":"Krug, K. et al. Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Cell https:\/\/doi.org\/10.1016\/j.cell.2020.10.036 (2020).","DOI":"10.1016\/j.cell.2020.10.036"},{"key":"37547_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette, M. A. et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200\u2013225.e35 (2020).","journal-title":"Cell"},{"key":"37547_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cell.2020.01.026","volume":"180","author":"Y Dou","year":"2020","unstructured":"Dou, Y. et al. Proteogenomic characterization of endometrial carcinoma. Cell 180, 729\u2013748.e26 (2020).","journal-title":"Cell"},{"key":"37547_CR16","doi-asserted-by":"publisher","unstructured":"Wang, L.-B. et al. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell https:\/\/doi.org\/10.1016\/j.ccell.2021.01.006 (2021).","DOI":"10.1016\/j.ccell.2021.01.006"},{"key":"37547_CR17","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/j.cell.2021.07.016","volume":"184","author":"S Satpathy","year":"2021","unstructured":"Satpathy, S. et al. A proteogenomic portrait of lung squamous cell carcinoma. Cell 184, 4348\u20134371.e40 (2021).","journal-title":"Cell"},{"key":"37547_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55\u201362 (2016).","journal-title":"Nature"},{"key":"37547_CR19","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41596-018-0006-9","volume":"13","author":"P Mertins","year":"2018","unstructured":"Mertins, P. et al. Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry. Nat. Protoc. 13, 1632\u20131661 (2018).","journal-title":"Nat. Protoc."},{"key":"37547_CR20","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/nprot.2013.120","volume":"8","author":"ND Udeshi","year":"2013","unstructured":"Udeshi, N. D., Mertins, P., Svinkina, T. & Carr, S. A. Large-scale identification of ubiquitination sites by mass spectrometry. Nat. Protoc. 8, 1950\u20131960 (2013).","journal-title":"Nat. Protoc."},{"key":"37547_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cels.2016.08.009","volume":"3","author":"CM Rose","year":"2016","unstructured":"Rose, C. M. et al. Highly multiplexed quantitative mass spectrometry analysis of ubiquitylomes. Cell Syst. 3, 395\u2013403.e4 (2016).","journal-title":"Cell Syst."},{"key":"37547_CR22","doi-asserted-by":"publisher","first-page":"662443","DOI":"10.3389\/fimmu.2021.662443","volume":"12","author":"N Olsson","year":"2021","unstructured":"Olsson, N. et al. An integrated genomic, proteomic, and immunopeptidomic approach to discover treatment-induced neoantigens. Front. Immunol. 12, 662443 (2021).","journal-title":"Front. Immunol."},{"key":"37547_CR23","doi-asserted-by":"publisher","first-page":"109542","DOI":"10.1016\/j.biopha.2019.109542","volume":"120","author":"X Zhang","year":"2019","unstructured":"Zhang, X., Qi, Y., Zhang, Q. & Liu, W. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy. Biomed. Pharmacother. 120, 109542 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"37547_CR24","doi-asserted-by":"publisher","first-page":"100133","DOI":"10.1016\/j.mcpro.2021.100133","volume":"20","author":"S Klaeger","year":"2021","unstructured":"Klaeger, S. et al. Optimized liquid and gas phase fractionation increases HLA-peptidome coverage for primary cell and tissue samples. Mol. Cell. Proteom. 20, 100133 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nbt.4313","volume":"37","author":"B Bulik-Sullivan","year":"2018","unstructured":"Bulik-Sullivan, B. et al. Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification. Nat. Biotechnol. 37, 55 (2018).","journal-title":"Nat. Biotechnol."},{"key":"37547_CR26","doi-asserted-by":"publisher","first-page":"e146356","DOI":"10.1172\/jci.insight.146356","volume":"6","author":"T Hirama","year":"2021","unstructured":"Hirama, T. et al. Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue. JCI Insight 6, e146356 (2021).","journal-title":"JCI Insight"},{"key":"37547_CR27","doi-asserted-by":"crossref","unstructured":"Bauer, J. et al. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. Nat. Commun. 13, 6401 (2022).","DOI":"10.1038\/s41467-022-33746-3"},{"key":"37547_CR28","doi-asserted-by":"crossref","unstructured":"Nicholas, B. et al. Identification of neoantigens in oesophageal adenocarcinoma. Immunology 168, 420\u2013431 (2023).","DOI":"10.1111\/imm.13578"},{"key":"37547_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s42003-022-03807-w","volume":"5","author":"Y Minegishi","year":"2022","unstructured":"Minegishi, Y. et al. Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations. Commun. Biol. 5, 831 (2022).","journal-title":"Commun. Biol."},{"key":"37547_CR30","doi-asserted-by":"publisher","first-page":"662443","DOI":"10.3389\/fimmu.2021.662443","volume":"12","author":"N Olsson","year":"2021","unstructured":"Olsson, N. et al. An integrated genomic, proteomic, and immunopeptidomic approach to discover treatment-induced neoantigens. Front. Immunol. 12, 662443 (2021).","journal-title":"Front. Immunol."},{"key":"37547_CR31","doi-asserted-by":"crossref","unstructured":"Wang, Q. et al. Direct detection and quantification of neoantigens. Cancer Immunol. Res. 7 1748\u20131754 (2019).","DOI":"10.1158\/2326-6066.CIR-19-0107"},{"key":"37547_CR32","doi-asserted-by":"publisher","first-page":"100136","DOI":"10.1016\/j.mcpro.2021.100136","volume":"20","author":"YA Qi","year":"2021","unstructured":"Qi, Y. A. et al. Proteogenomic analysis unveils the HLA class I-presented immunopeptidome in melanoma and EGFR-mutant lung adenocarcinoma. Mol. Cell. Proteom. 20, 100136 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR33","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","volume":"184","author":"S Weingarten-Gabbay","year":"2021","unstructured":"Weingarten-Gabbay, S. et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell 184, 3962\u20133980.e17 (2021).","journal-title":"Cell"},{"key":"37547_CR34","doi-asserted-by":"publisher","first-page":"109305","DOI":"10.1016\/j.celrep.2021.109305","volume":"35","author":"A Nagler","year":"2021","unstructured":"Nagler, A. et al. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics. Cell Rep. 35, 109305 (2021).","journal-title":"Cell Rep."},{"key":"37547_CR35","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1073\/pnas.1423482112","volume":"112","author":"DB Keskin","year":"2015","unstructured":"Keskin, D. B. et al. Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity. Proc. Natl Acad. Sci. USA 112, 2151\u20132156 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37547_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14968-9","volume":"11","author":"C Chong","year":"2020","unstructured":"Chong, C. et al. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat. Commun. 11, 1293 (2020).","journal-title":"Nat. Commun."},{"key":"37547_CR37","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1021\/acs.jproteome.8b00505","volume":"17","author":"M HaileMariam","year":"2018","unstructured":"HaileMariam, M. et al. S-trap, an ultrafast sample-preparation approach for shotgun proteomics. J. Proteome Res. 17, 2917\u20132924 (2018).","journal-title":"J. Proteome Res."},{"key":"37547_CR38","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.mcpro.2021.100154","volume":"20","author":"KD Rivera","year":"2021","unstructured":"Rivera, K. D. et al. Automating UbiFast for high-throughput and multiplexed ubiquitin enrichment. Mol. Cell. Proteom. 20, 100154 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1074\/mcp.TIR117.000383","volume":"17","author":"C Chong","year":"2018","unstructured":"Chong, C. et al. High-throughput and sensitive immunopeptidomics platform reveals profound interferon\u03b3-mediated remodeling of the Human Leukocyte Antigen (HLA) Ligandome. Mol. Cell. Proteom. 17, 533\u2013548 (2018).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR40","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.mcpro.2021.100108","volume":"20","author":"SB Pollock","year":"2021","unstructured":"Pollock, S. B. et al. Sensitive and quantitative detection of MHC-I displayed neoepitopes using a semiautomated workflow and TOMAHAQ mass spectrometry. Mol. Cell. Proteom. 20, 100108 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/acs.jproteome.0c00464","volume":"20","author":"L Zhang","year":"2021","unstructured":"Zhang, L., McAlpine, P. L., Heberling, M. L. & Elias, J. E. Automated ligand purification platform accelerates immunopeptidome analysis by mass spectrometry. J. Proteome Res. 20, 393\u2013408 (2021).","journal-title":"J. Proteome Res."},{"key":"37547_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20166-4","volume":"11","author":"EC Jappe","year":"2020","unstructured":"Jappe, E. C. et al. Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design. Nat. Commun. 11, 6305 (2020).","journal-title":"Nat. Commun."},{"key":"37547_CR43","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1074\/mcp.M116.058354","volume":"15","author":"JG Abelin","year":"2016","unstructured":"Abelin, J. G. et al. Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes. Mol. Cell. Proteom. 15, 1622\u20131641 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR44","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.celrep.2013.08.022","volume":"4","author":"S Li","year":"2013","unstructured":"Li, S. et al. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep. 4, 1116\u20131130 (2013).","journal-title":"Cell Rep."},{"key":"37547_CR45","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37547_CR46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1074\/mcp.TIR118.000943","volume":"18","author":"K Krug","year":"2019","unstructured":"Krug, K. et al. A curated resource for phosphosite-specific signature analysis. Mol. Cell. Proteom. 18, 576\u2013593 (2019).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lungcan.2017.07.030","volume":"112","author":"Y He","year":"2017","unstructured":"He, Y. et al. MHC class II expression in lung cancer. Lung Cancer 112, 75\u201380 (2017).","journal-title":"Lung Cancer"},{"key":"37547_CR48","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3389\/fimmu.2018.02144","volume":"9","author":"JE Wosen","year":"2018","unstructured":"Wosen, J. E., Mukhopadhyay, D., Macaubas, C. & Mellins, E. D. Epithelial MHC class II expression and its role in antigen presentation in the gastrointestinal and respiratory tracts. Front. Immunol. 9, 2144 (2018).","journal-title":"Front. Immunol."},{"key":"37547_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/bioinformatics\/btz474","volume":"36","author":"R Orenbuch","year":"2020","unstructured":"Orenbuch, R. et al. arcasHLA: high-resolution HLA typing from RNAseq. Bioinformatics 36, 33\u201340 (2020).","journal-title":"Bioinformatics"},{"key":"37547_CR50","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.tibs.2018.07.002","volume":"43","author":"AM James","year":"2018","unstructured":"James, A. M. et al. The causes and consequences of nonenzymatic protein acylation. Trends Biochem. Sci. 43, 921\u2013932 (2018).","journal-title":"Trends Biochem. Sci."},{"key":"37547_CR51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1399-0039.1998.tb02994.x","volume":"51","author":"MJ Shields","year":"1998","unstructured":"Shields, M. J. & Ribaudo, R. K. Mapping of the monoclonal antibody W6\/32: sensitivity to the amino terminus of \u03b22-microglobulin. Tissue Antigens 51, 567\u2013570 (1998).","journal-title":"Tissue Antigens"},{"key":"37547_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41587-021-01021-3","volume":"40","author":"T Ouspenskaia","year":"2021","unstructured":"Ouspenskaia, T. et al. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat. Biotechnol. 40, 209\u2013217 (2021).","journal-title":"Nat. Biotechnol."},{"key":"37547_CR53","doi-asserted-by":"publisher","first-page":"D816","DOI":"10.1093\/nar\/gkn673","volume":"37","author":"LG Almeida","year":"2009","unstructured":"Almeida, L. G. et al. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res. 37, D816\u2013D819 (2009).","journal-title":"Nucleic Acids Res."},{"key":"37547_CR54","doi-asserted-by":"publisher","first-page":"e86837","DOI":"10.1172\/jci.insight.86837","volume":"1","author":"D Djureinovic","year":"2016","unstructured":"Djureinovic, D. et al. Profiling cancer testis antigens in non-small-cell lung cancer. JCI Insight 1, e86837 (2016).","journal-title":"JCI Insight"},{"key":"37547_CR55","doi-asserted-by":"publisher","first-page":"108815","DOI":"10.1016\/j.celrep.2021.108815","volume":"34","author":"MV Ruiz Cuevas","year":"2021","unstructured":"Ruiz Cuevas, M. V. et al. Most non-canonical proteins uniquely populate the proteome or immunopeptidome. Cell Rep. 34, 108815 (2021).","journal-title":"Cell Rep."},{"key":"37547_CR56","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","volume":"515","author":"M Yadav","year":"2014","unstructured":"Yadav, M. et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515, 572\u2013576 (2014).","journal-title":"Nature"},{"key":"37547_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"37547_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","volume":"6","author":"K Ellrott","year":"2018","unstructured":"Ellrott, K. et al. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Syst. 6, 271\u2013281.e7 (2018).","journal-title":"Cell Syst."},{"key":"37547_CR59","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1074\/mcp.M115.056226","volume":"15","author":"KV Ruggles","year":"2016","unstructured":"Ruggles, K. V. et al. An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer. Mol. Cell. Proteom. 15, 1060\u20131071 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR60","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.crmeth.2021.100084","volume":"1","author":"J Choi","year":"2021","unstructured":"Choi, J. et al. Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations. Cell Rep. Methods 1, 100084 (2021).","journal-title":"Cell Rep. Methods"},{"key":"37547_CR61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1158\/2326-6066.CIR-15-0188","volume":"4","author":"QJ Wang","year":"2016","unstructured":"Wang, Q. J. et al. Identification of T-cell receptors targeting KRAS-mutated human tumors. Cancer Immunol. Res. 4, 204\u2013214 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"37547_CR62","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612\u20132612 (2013).","journal-title":"Nat. Commun."},{"key":"37547_CR63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/mcp.TIR119.001641","volume":"19","author":"M Solleder","year":"2020","unstructured":"Solleder, M. et al. Mass spectrometry based immunopeptidomics leads to robust predictions of phosphorylated HLA class I ligands. Mol. Cell. Proteom. 19, 390\u2013404 (2020).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR64","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1084\/jem.192.12.1755","volume":"192","author":"AL Zarling","year":"2000","unstructured":"Zarling, A. L. et al. Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J. Exp. Med. 192, 1755\u20131762 (2000).","journal-title":"J. Exp. Med."},{"key":"37547_CR65","doi-asserted-by":"publisher","first-page":"203ra125","DOI":"10.1126\/scitranslmed.3006061","volume":"5","author":"M Cobbold","year":"2013","unstructured":"Cobbold, M. et al. MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Sci. Transl. Med. 5, 203ra125\u2013203ra125 (2013).","journal-title":"Sci. Transl. Med."},{"key":"37547_CR66","doi-asserted-by":"publisher","first-page":"723566","DOI":"10.3389\/fimmu.2021.723566","volume":"12","author":"SA Penny","year":"2021","unstructured":"Penny, S. A. et al. Tumor infiltrating lymphocytes target HLA-I phosphopeptides derived from cancer signaling in colorectal cancer. Front. Immunol. 12, 723566 (2021).","journal-title":"Front. Immunol."},{"key":"37547_CR67","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.immuni.2019.08.012","volume":"51","author":"JG Abelin","year":"2019","unstructured":"Abelin, J. G. et al. Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction. Immunity 51, 766\u2013779.e17 (2019).","journal-title":"Immunity"},{"key":"37547_CR68","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41587-019-0289-6","volume":"37","author":"J Racle","year":"2019","unstructured":"Racle, J. et al. Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes. Nat. Biotechnol. 37, 1283\u20131286 (2019).","journal-title":"Nat. Biotechnol."},{"key":"37547_CR69","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz, V. et al. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J. Immunol. 199, 3360\u20133368 (2017).","journal-title":"J. Immunol."},{"key":"37547_CR70","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1600808","volume":"197","author":"M Bassani-Sternberg","year":"2016","unstructured":"Bassani-Sternberg, M. & Gfeller, D. Unsupervised HLA peptidome deconvolution improves ligand prediction accuracy and predicts cooperative effects in peptide\u2013HLA interactions. J. Immunol. 197, 2492 (2016).","journal-title":"J. Immunol."},{"key":"37547_CR71","doi-asserted-by":"crossref","unstructured":"Yanovich-Arad, G. et al. Proteogenomics of glioblastoma associates molecular patterns with survival. Cell Rep. 34, 108787 (2021).","DOI":"10.1016\/j.celrep.2021.108787"},{"key":"37547_CR72","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ccell.2019.02.005","volume":"35","author":"A Sinha","year":"2019","unstructured":"Sinha, A. et al. The proteogenomic landscape of curable prostate cancer. Cancer Cell 35, 414\u2013427.e6 (2019).","journal-title":"Cancer Cell"},{"key":"37547_CR73","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ccell.2020.08.002","volume":"38","author":"C Li","year":"2020","unstructured":"Li, C. et al. Integrated omics of metastatic colorectal cancer. Cancer Cell 38, 734\u2013747.e9 (2020).","journal-title":"Cancer Cell"},{"key":"37547_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09018-y","volume":"10","author":"HJ Johansson","year":"2019","unstructured":"Johansson, H. J. et al. Breast cancer quantitative proteome and proteogenomic landscape. Nat. Commun. 10, 1600 (2019).","journal-title":"Nat. Commun."},{"key":"37547_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11452-x","volume":"10","author":"PA Stewart","year":"2019","unstructured":"Stewart, P. A. et al. Proteogenomic landscape of squamous cell lung cancer. Nat. Commun. 10, 3578 (2019).","journal-title":"Nat. Commun."},{"key":"37547_CR76","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40478-018-0548-7","volume":"6","author":"S Rivero-Hinojosa","year":"2018","unstructured":"Rivero-Hinojosa, S. et al. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential. Acta Neuropathol. Commun. 6, 48 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"37547_CR77","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ccell.2020.12.007","volume":"39","author":"C Huang","year":"2021","unstructured":"Huang, C. et al. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell 39, 361\u2013379.e16 (2021).","journal-title":"Cancer Cell"},{"key":"37547_CR78","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao, L. et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 184, 5031\u20135052.e26 (2021).","journal-title":"Cell"},{"key":"37547_CR79","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1074\/mcp.RA118.001259","volume":"18","author":"SA Myers","year":"2019","unstructured":"Myers, S. A. et al. Streamlined protocol for deep proteomic profiling of FAC-sorted cells and its application to freshly isolated murine immune cells. Mol. Cell. Proteom. 18, 995\u20131009 (2019).","journal-title":"Mol. Cell. Proteom."},{"key":"37547_CR80","doi-asserted-by":"publisher","unstructured":"Ctortecka, C. et al. An automated workflow for label-free and multiplexed single cell proteomics sample preparation at unprecedented sensitivity. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.04.14.439828 (2022).","DOI":"10.1101\/2021.04.14.439828"},{"key":"37547_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14381-2","volume":"11","author":"S Satpathy","year":"2020","unstructured":"Satpathy, S. et al. Microscaled proteogenomic methods for precision oncology. Nat. Commun. 11, 532 (2020).","journal-title":"Nat. Commun."},{"key":"37547_CR82","doi-asserted-by":"crossref","unstructured":"Yi, L. et al. Boosting to amplify signal with isobaric labeling (BASIL) strategy for comprehensive quantitative phosphoproteomic characterization of small populations of cells. Anal. Chem. 91, 5794\u20135801 (2019).","DOI":"10.1021\/acs.analchem.9b00024"},{"key":"37547_CR83","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nature08989","volume":"464","author":"L Ding","year":"2010","unstructured":"Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999\u20131005 (2010).","journal-title":"Nature"},{"key":"37547_CR84","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"37547_CR85","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"37547_CR86","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220\u20131222 (2016).","journal-title":"Bioinformatics"},{"key":"37547_CR87","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41592-018-0036-9","volume":"15","author":"A Taylor-Weiner","year":"2018","unstructured":"Taylor-Weiner, A. et al. DeTiN: overcoming tumor-in-normal contamination. Nat. Methods 15, 531\u2013534 (2018).","journal-title":"Nat. Methods"},{"key":"37547_CR88","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811\u20131817 (2012).","journal-title":"Bioinformatics"},{"key":"37547_CR89","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"37547_CR90","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","volume":"25","author":"K Ye","year":"2009","unstructured":"Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865\u20132871 (2009).","journal-title":"Bioinformatics"},{"key":"37547_CR91","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.cell.2018.07.034","volume":"174","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 174, 1034\u20131035 (2018).","journal-title":"Cell"},{"key":"37547_CR92","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/s41592-021-01301-5","volume":"18","author":"R Bouwmeester","year":"2021","unstructured":"Bouwmeester, R., Gabriels, R., Hulstaert, N., Martens, L. & Degroeve, S. DeepLC can predict retention times for peptides that carry as-yet unseen modifications. Nat. Methods 18, 1363\u20131369 (2021).","journal-title":"Nat. Methods"},{"key":"37547_CR93","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","volume":"20","author":"A Lex","year":"2014","unstructured":"Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R. & Pfister, H. UpSet: visualization of intersecting sets. IEEE Trans. Vis. Comput. Graph. 20, 1983\u20131992 (2014).","journal-title":"IEEE Trans. Vis. Comput. Graph."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37547-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37547-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37547-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T12:05:43Z","timestamp":1680523543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37547-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37547"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-37547-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"25 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A.C. is a member of the scientific advisory boards of Kymera, PTM BioLabs, Seer and PrognomIQ. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1851"}}